Michael Goggins

Active 1996–2026

245
Papers
66,888
Citations
137
h-index
242
i10-index

Citations

Citations per year for Michael Goggins1985: 1 citations1986: 1 citations1989: 1 citations1997: 7 citations1998: 17 citations1999: 50 citations2000: 75 citations2001: 82 citations2002: 166 citations2003: 280 citations2004: 293 citations2005: 414 citations2006: 453 citations2007: 435 citations2008: 465 citations2009: 456 citations2010: 565 citations2011: 728 citations2012: 651 citations2013: 617 citations2014: 778 citations2015: 785 citations2016: 730 citations2017: 690 citations2018: 718 citations2019: 2,338 citations2020: 2,548 citations2021: 2,550 citations2022: 1,831 citations2023: 1,534 citations2024: 2,084 citations2025: 1,026 citations2026: 25 citations1987–1988: no citations, so these years are not shown1990–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,726 citing papers, 29.4% of this breakdownChina: 2,765 citing papers, 12.1% of this breakdownUnited Kingdom: 1,314 citing papers, 5.7% of this breakdownGermany: 1,234 citing papers, 5.4% of this breakdownItaly: 1,151 citing papers, 5% of this breakdownJapan: 987 citing papers, 4.3% of this breakdownCanada: 710 citing papers, 3.1% of this breakdownFrance: 672 citing papers, 2.9% of this breakdownSpain: 650 citing papers, 2.8% of this breakdownNetherlands: 636 citing papers, 2.8% of this breakdownAustralia: 618 citing papers, 2.7% of this breakdownSouth Korea: 410 citing papers, 1.8% of this breakdown
0%29.4%Other 22%

Fields

  • Medicine47.8%
  • Biochemistry, Genetics and Molecular Biology44.8%
  • Immunology and Microbiology2%
  • Chemistry1.2%
  • Engineering1%
  • Neuroscience0.8%
  • Other2.4%

Topics

  • Pancreatic and Hepatic Oncology Research10.2%
  • Cancer Genomics and Diagnostics8.3%
  • Epigenetics and DNA Methylation3.3%
  • Cancer Cells and Metastasis3.3%
  • Pancreatitis Pathology and Treatment2.7%
  • Genetic factors in colorectal cancer2.4%
  • Other69.8%

Coauthors

All papers

Open in search
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 cited by 5,110

  2. Detection and localization of surgically resectable cancers with a multi-analyte blood test

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin Jen, Samir Hanash, Massimo Falconi, Peter J. Allen, Shibin Zhou, Chetan Bettegowda, Luis A. Díaz, Cristian Tomasetti, Kenneth W. Kinzler, Bert Vogelstein, Anne Marie Lennon, Nickolas Papadopoulos - Science 2018 cited by 2,853

  3. Pancreatic cancer

    Authors: , , , , - The Lancet 2011 cited by 2,596

  4. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristen M. Shannon, Rebecca Shatsky, Kala Visvanathan, Jeffrey N. Weitzel, Myra Wick, Kari B. Wisinski, Matthew B. Yurgelun, Susan Darlow, Mary A. Dwyer - Journal of the National Comprehensive Cancer Network 2021 cited by 1,115

  5. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention

    Authors: , , - Gastroenterology 2023 cited by 458

  6. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler - Science 2008 cited by 4,055

  7. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 625

  8. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 224

  9. Detecting Liver Cancer Using Cell-Free DNA Fragmentomes

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 cited by 154

  10. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gwen Reiser, Leigha Senter-Jamieson, Kristen M. Shannon, Kala Visvanathan, Jeanna Welborn, Myra Wick, Marie Wood, Matthew B. Yurgelun, Mary A. Dwyer, Susan Darlow - Journal of the National Comprehensive Cancer Network 2023 cited by 290

  11. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Popoli, Michael Goggins, Ralph H. Hruban, Christopher L. Wolfgang, Alison P. Klein, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Anne Marie Lennon - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 572

  12. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Surgical Pathology 2015 cited by 834

  13. Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

    Authors: , , , , , , , , , , - Gastroenterology 2012 cited by 722

  14. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis

    Authors: , , , , - JNCI Journal of the National Cancer Institute 2020 cited by 256

  15. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deepak Nagrath, Anirban Maitra, Amit Verma - eLife 2019 cited by 167

  16. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 401

  17. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2019 cited by 282

  18. Long Interspersed Element-1 Protein Expression Is a Hallmark of Many Human Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2014 cited by 371

  19. A multimodality test to guide the management of patients with a pancreatic cyst

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Massimo Falconi, Stefano Crippa, Claudio Doglioni, Jorge Paulino, Richard D. Schulick, Barish H. Edil, Walter G. Park, Shinichi Yachida, Susumu Hijioka, Jeanin E. van Hooft, Jin He, Matthew J. Weiss, Richard A. Burkhart, Martin A. Makary, Marcia Irene Canto, Michael Goggins, Janine Ptak, Lisa Dobbyn, Joy Schaefer, Natalie Sillman, Maria Popoli, Alison P. Klein, Cristian Tomasetti, Rachel Karchin, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Christopher L. Wolfgang, Ralph H. Hruban, Anne Marie Lennon - Science Translational Medicine 2019 cited by 207

  20. Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer

    Authors: , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2020 cited by 102

  21. Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2011 cited by 520

  22. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco J. Bruno - Gastroenterology 2021 cited by 110

  23. Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 cited by 193

  24. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 482